Fatima Suleman

Dr Fatima Suleman is a member of the 2024 Expert Review Committee for the Access to Medicine Index, having been a member of the 2022 Committee. She is also a member of the 2022 Expert Review Committee for the Generic & Biosimilar Medicines Programme. Dr Suleman is a Professor in the School of Health Sciences, University of KwaZulu-Natal and Professor, and Director of the World Health Organization Collaborating Centre for Pharmaceutical Policy and Evidence Based Practice.

Dr Suleman is a former Prince Claus Chair of Development and Equity: Affordable (Bio)Therapeutics for Public Health (until September 2018) at Utrecht University, and a Fulbright Alumnus (Fulbright Scholar 2002-2004). She was appointed by the South African Minister of Health to serve on the National Pricing Committee (2010-2020).

Dr Suleman has been appointed to the World Health Organization's Expert Advisory Panel on Drug Evaluation (2017 - 2021). She is an EXCO member for the African Forum on Research and Education in Health (AFREhealth) PI Council (current). She has served on a number of WHO committees over the years and been a technical advisor on pharmaceutical policy for a number of countries. She has a number of publications in the area of pharmaceutical policy and medicine use.